Critical incidents in paediatric critical care: who is at risk?

Oliver W Niesse1, Felix H Sennhauser, Bernhard Frey

  • 1Department of Intensive Care and Neonatology, University Children's Hospital, Zurich, Switzerland. oliver.niesse@kispi.uzh.ch

Insights

Critical incidents (CIs) frequently occur in pediatric intensive care. Male gender, mechanical ventilation, and longer hospital stays are independently linked to CIs in children, aiding in quality improvement.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Patient Safety
  • Healthcare Quality Improvement

Background:

  • Critical incidents (CIs), including adverse events and near-misses, are a concern in pediatric intensive care units (PICUs).
  • Understanding patient-specific risk factors is crucial for developing targeted safety interventions.

Purpose of the Study:

  • To evaluate patient characteristics associated with critical incidents (CIs) in a multidisciplinary neonatal-paediatric intensive care unit.
  • To identify independent risk factors for CIs to inform strategies for reducing their occurrence and improving care quality.

Main Methods:

  • Prospective data collection and retrospective review of CI reports over one year (2007) in a tertiary care university children's hospital.
  • Analysis of 360 CI reports, comparing patients with and without CIs based on factors like PIM2 score, ventilation duration, length of stay, and demographics.
  • Logistic regression modeling to identify independent predictors of CI occurrence.

Main Results:

  • A total of 360 CI reports were analyzed, with 198 patients experiencing 310 CIs.
  • Univariate analysis showed higher PIM2 scores, longer ICU stays, mechanical ventilation, and male gender were associated with CIs.
  • Logistic regression confirmed mechanical ventilation, male gender, and length of stay as independent risk factors for CIs.

Conclusions:

  • Critical incidents are common in pediatric intensive care.
  • Male gender, need for mechanical ventilation, and prolonged length of stay are significant patient-related factors associated with CIs.
  • Identifying these risk factors can guide interventions to minimize CI frequency and enhance patient safety in PICUs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...